Presentation is loading. Please wait.

Presentation is loading. Please wait.

Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201  Hisao Asamura, MD, Tomoyuki.

Published byBrook Walton Modified over 6 years ago

Similar presentations

Presentation on theme: "Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201  Hisao Asamura, MD, Tomoyuki."— Presentation transcript:

1 Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201  Hisao Asamura, MD, Tomoyuki Hishida, MD, Kenji Suzuki, MD, Teruaki Koike, MD, Kenichi Nakamura, MD, Masahiko Kusumoto, MD, Kanji Nagai, MD, Hirohito Tada, MD, Tetsuya Mitsudomi, MD, Masahiro Tsuboi, MD, Taro Shibata, MSc, Haruhiko Fukuda, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 146, Issue 1, Pages (July 2013) DOI: /j.jtcvs Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Calculation of the C/T ratio to define radiologic noninvasive lung cancer on TSCT. The maximum diameter of consolidation (C) is divided by the maximum tumor diameter (T) to give the C/T ratio. GGO, Ground-glass opacity; C/T, consolidation/tumor; TSCT, thin-section computed tomography. The Journal of Thoracic and Cardiovascular Surgery  , 24-30DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Overall (A) and relapse-free (B) survival curves for the entire group (cT1a-b, ≤3.0 cm, n = 545). OS, Overall survival; RFS, relapse-free survival. The Journal of Thoracic and Cardiovascular Surgery  , 24-30DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 Overall (A) and relapse-free (B) survival curves for radiologically noninvasive (n = 121) and invasive (n = 424) adenocarcinomas based on a C/T ratio of 0.50 or less in cT1a-b (≤3.0 cm) for noninvasiveness on TSCT. The differences in overall and relapse-free survival are statistically significant (P < .001 and < .001, respectively). OS, Overall survival; RFS, relapse-free survival; C/T, consolidation/tumor; TSCT, thin-section computed tomography. The Journal of Thoracic and Cardiovascular Surgery  , 24-30DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

5 Figure 4 Overall (A) and relapse-free (B) survival curves for the cT1a (≤2.0 cm) group (n = 289). OS, Overall survival; RFS, relapse-free survival. The Journal of Thoracic and Cardiovascular Surgery  , 24-30DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

6 Figure 5 Overall (A) and relapse-free (B) survival curves for radiologically noninvasive (n = 35) and invasive (n = 254) adenocarcinomas based on a C/T ratio of 0.25 or less in cT1a (≤2.0 cm) for noninvasiveness on TSCT. The differences in overall and relapse-free survival are not statistically significant (P = .259 and .106, respectively). OS, Overall survival; RFS, relapse-free survival; C/T, consolidation/tumor; TSCT, thin-section computed tomography. The Journal of Thoracic and Cardiovascular Surgery  , 24-30DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

7 Figure 6 Overall (A) and relapse-free (B) survival curves for radiologically noninvasive (n = 54) and invasive (n = 200) adenocarcinomas based on a C/T ratio ≤0.5 in cT1b (> cm) for noninvasiveness on TSCT. The differences in overall and relapse-free survival are statistically significant (P = .003 and .003, respectively). OS, Overall survival; RFS, relapse-free survival; C/T, consolidation/tumor; TSCT, thin-section computed tomography. The Journal of Thoracic and Cardiovascular Surgery  , 24-30DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201  Hisao Asamura, MD, Tomoyuki."

Similar presentations

Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma  Kazuya Takamochi, MD, Shiaki Oh, MD,

Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma  Kazuya Takamochi, MD, Shiaki Oh, MD,
Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.

Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size  Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.

A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size  Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.
Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.

Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.
Lung cancer screening: No more excuses

Lung cancer screening: No more excuses
Interventional radiology suite or hybrid operating room: Which is the best for lung nodule localization?  Robert B. Cameron, MD  The Journal of Thoracic.

Interventional radiology suite or hybrid operating room: Which is the best for lung nodule localization?  Robert B. Cameron, MD  The Journal of Thoracic.
Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies.

Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies.
Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study  Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.

Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study  Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
Ground glass opacity of the lung: The veil that needs lifting

Ground glass opacity of the lung: The veil that needs lifting
Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid.

Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid.
Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer  Aritoshi Hattori, MD, Takeshi Matsunaga, MD, Kazuya.

Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer  Aritoshi Hattori, MD, Takeshi Matsunaga, MD, Kazuya.
Oncological Characteristics of Radiological Invasive Adenocarcinoma with Additional Ground-Glass Nodules on Initial Thin-Section Computed Tomography:

Oncological Characteristics of Radiological Invasive Adenocarcinoma with Additional Ground-Glass Nodules on Initial Thin-Section Computed Tomography:
Clinicopathologic Features of Resected Subcentimeter Lung Cancer

Clinicopathologic Features of Resected Subcentimeter Lung Cancer
How Long Should Small Lung Lesions of Ground-Glass Opacity be Followed?  Yoshihisa Kobayashi, MD, Takayuki Fukui, MD, Simon Ito, MD, Noriyasu Usami, MD,

How Long Should Small Lung Lesions of Ground-Glass Opacity be Followed?  Yoshihisa Kobayashi, MD, Takayuki Fukui, MD, Simon Ito, MD, Noriyasu Usami, MD,
Lung Cancer with Localized Ground-Glass Attenuation Represents Early-Stage Adenocarcinoma in Nonsmokers  Nobuhiko Seki, MD, Shigeki Sawada, MD, Masao.

Lung Cancer with Localized Ground-Glass Attenuation Represents Early-Stage Adenocarcinoma in Nonsmokers  Nobuhiko Seki, MD, Shigeki Sawada, MD, Masao.
Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non–Small Cell Lung Cancer  Aritoshi Hattori, MD,

Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non–Small Cell Lung Cancer  Aritoshi Hattori, MD,
Propensity score–matched analysis of adjuvant chemotherapy for stage I non–small cell lung cancer  Yasuhiro Tsutani, MD, PhD, Yoshihiro Miyata, MD, PhD,

Propensity score–matched analysis of adjuvant chemotherapy for stage I non–small cell lung cancer  Yasuhiro Tsutani, MD, PhD, Yoshihiro Miyata, MD, PhD,
The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma  Yasuhiro Tsutani, MD, PhD, Yoshihiro.

The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma  Yasuhiro Tsutani, MD, PhD, Yoshihiro.

Similar presentations

Ads by Google